Literature DB >> 6838514

Evidence for a cytosolic precursor of chick embryo liver mitochondrial delta-aminolevulinate synthase.

G Srivastava, I A Borthwick, J D Brooker, B K May, W H Elliott.   

Abstract

Following the recent demonstration [Borthwick, I.A., Srivastava, G., Brooker, J.D., May, B.K. and Elliott, W.H. (1982) Eur. J. Biochem. in press] that chick embryo liver mitochondrial delta-aminolevulinate synthase has a minimum molecular weight of 68,000 (rather than the hitherto accepted value of 49,000), we have shown that the primary translation product of delta-aminolevulinate synthase mRNA is a protein of molecular weight 74,000. This protein has for the first time been shown to occur in the cytosol fraction of drug-treated chick embryo livers. This form does not occur in mitochondria nor does the smaller mitochondrial form occur in the cytosol. It is concluded that the 74,000 molecular weight protein is a precursor which is processed during transport into the mitochondria. In vivo labelling experiments are consistent with this conclusion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6838514     DOI: 10.1016/0006-291x(83)91254-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Cloning by genetic complementation and restriction mapping of the yeast HEM1 gene coding for 5-aminolevulinate synthase.

Authors:  D Urban-Grimal; V Ribes; R Labbe-Bois
Journal:  Curr Genet       Date:  1984-07       Impact factor: 3.886

2.  Biogenesis of mitochondrial proteins. Regulation of production of delta-aminolaevulinate synthase by haemin in embryonic-chick liver.

Authors:  I Z Ades; K G Harpe; T M Stevens
Journal:  Biochem J       Date:  1983-09-15       Impact factor: 3.857

3.  Expression of murine 5-aminolevulinate synthase variants causes protoporphyrin IX accumulation and light-induced mammalian cell death.

Authors:  Erica J Fratz; Gregory A Hunter; Gloria C Ferreira
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.